You are here

  • Home
  • Archive
  • Volume 65, Issue 5
  • Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF
Extended report
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

Authors

  1. Correspondence to:
    Professor J-Y Reginster
    Unité d’Exploration du Metabolisme de l’Os et du Cartilage, CHU Centre Ville, Liège, Belgium; jyreginster{at}ulg.ac.be
View Full Text

Citation

Reginster J, Adami S, Lakatos P, et al
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
Annals of the Rheumatic Diseases 2006;65:654-661.

Publication history

  • Accepted November 27, 2005
  • First published December 8, 2005.
Online issue publication 
December 29, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright 2006 by Annals of the Rheumatic Diseases